<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="migraine/PMC6826633/results/search/funders/results.xml">
  <result pre="increasingly widespread since vagus nerve stimulation (VNS) gained United States" exact="Food and Drug Administration" post="(FDA) approval in 1997 [ 5]. Various modalities exist,"/>
  <result pre="been implemented via off-label usage of FDA-approved hardware manufactured by" exact="Medtronic" post="(Dublin, Eire and Minneapolis, MN, USA) that is approved"/>
  <result pre="critically revised the manuscript. Funding B.N.L. was supported by the" exact="Mayo Clinic" post="Foundation and the NIH NINDS (K23NS112339). Conflicts of Interest"/>
  <result pre="Foundation and the NIH NINDS (K23NS112339). Conflicts of Interest The" exact="Mayo Clinic" post="(Rochester, MN, US) has a financial interest related to"/>
  <result pre="of epilepsy: Report of the Guideline Development Subcommittee of the" exact="American Academy of Neurology" post="Neurology 2013 81 1453 1459 10.1212/WNL.0b013e3182a393d1 23986299 30. Eggleston"/>
  <result pre="all cathodes and anodes. brainsci-09-00283-t001_Table 1 Table 1 Summary of" exact="Food and Drug Administration" post="(FDA)-approved Invasive Stimulation Approaches. Patient Factors (FDA Approval) Battery"/>
 </snippets>
</snippetsTree>
